RavenQuest BioMed Inc.

News Releases

29/04/2020

RQB - Press Release Bi weekly update

31/03/2020

Bulletins

13/05/2021

2021-0512 - Delist - RavenQuest BioMed Inc. (RQB)

Le 13 mai/May 2021

The common shares of RavenQuest BioMed Inc. will be delisted at the market close today May 13, 2021.

RavenQuest BioMed is currently suspended. See bulletin 2020-0519.

___________________

Les actions ordinaires de RavenQuest BioMed Inc. seront radiées à la clôture du marché aujourd'hui le 13 mai 2021.

12/05/2020

2020-0519 - Suspension – Ravenquest BioMed Inc. (RQB)

Le 12 mai/May 2020

Effective immediately Ravenquest BioMed Inc. is suspended pursuant to CSE Policy 3 for failure to comply with Exchange Requirements. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules.

____________________________

29/06/2018

2018-0630 - New Listing - RavenQuest BioMed Inc. - Warrants (RQB.WT)

Le 29 juin/June 2018

RavenQuest BioMed Inc. warrants have been approved for listing on the CSE.

Each warrant shall entitle the warrant holder thereof, upon exercise at any time after the issue date and prior to the expiry date to acquire one (1) share upon payment of the exercise price of $1.50 per warrant.

________________________

Les warrants RavenQuest BioMed Inc. ont été approuvés pour inscription sur le CSE.

03/10/2017

2017-1002 – Fundamental Change – Ravencrest Resources Inc./Ravenquest BioMed Inc.

le 3 octobre/October 2017

Ravenquest BioMed Inc., the issuer resulting from a Fundamental Change of Ravencrest Resourcese Inc. has been approved for listing.

Listing and disclosure documents will be available at thecse.com

17/10/2012

2012-1010 - Plan of Arrangement - Ravencrest Resources Inc.

Ravencrest Resources (the “Company” or “Ravencrest”) has announced the completion of the Arrangement Agreement with River Wild Exploration Inc.

03/11/2010

2010-1104 - New Listing - Ravencrest Resources Inc. (RVT)

November 3, 2010

The common shares of Ravencrest Resources Inc. have been approved for listing on CNSX. The Company has 27.5 million common shares outstanding with a public float of approximately 24.1 million shares.

CSE Filings

File	Type	Date
RQB Monthly progress - May	Monthly Progress Report	05/06/2020
RQB - MPR	Monthly Progress Report	07/05/2020
RQB - MPR	Monthly Progress Report	07/04/2020
RQB - Form 9	Notice of Issuance or Proposed Issuance of Listed Securities	11/03/2020
RQB - Form 9	Notice of Issuance or Proposed Issuance of Listed Securities	10/03/2020
RQB - 2020 FEB MPR	Monthly Progress Report	03/03/2020
RQB MPR	Monthly Progress Report	07/02/2020
Letter to the CSE - RQB	Other	15/01/2020
RQB - Form 6	Certificate of compliance	15/01/2020

1
2
3
4
5
6
7
8
9
…
next ›
last »

You are here